help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsueh, A. J.
Right arrow Articles by Clark, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsueh, A. J.
Right arrow Articles by Clark, J. H.

Endocrinology, Vol 98, 438-444, Copyright © 1976 by Endocrine Society


ARTICLES

Control of uterine estrogen receptor levels by progesterone

AJ Hsueh, EJ Peck Jr and JH Clark

The mechanism by which progesterone antagonizes estrogenic stimulation of uterine growth was examined in the immature rat. Rats received daily injections of 2.5 mug estradiol (E) for 2 days and on day 3 either 2.5 mug E or 2.5 mug E plus 2.5 mg of progesterone (P). The quantity of nuclear and cytoplasmic estrogen receptor was determined by [3H]estradiol exchange at various intervals after injection of E or E + P. In both groups, nuclear receptor estrogen complex (RnE) increased dramtically one hour after injection and showed a gradual decline from 4 to 24 h after injection. The quantity of cytoplasmic receptor, Rc, decreased to low levels by one hour and began a gradual increase from 4 to 8 h in both groups. However, between 8 and 24 h after injection, the level of Rc continued to increase in the E treatment group (2.39 +/- 0.21 pmol/uterus at 24 h) but remained at the 8 h level in the E + P group (1.09 +/- 0.04 pmol/uterus at 24 h). This observation suggests that two seperate processes are involved in the replenishment of Rc and that progesterone inhibits the second phase of replenishment. The binding affinity and specificity of Rc for estrogens following E + P pretreatment were identical to those of the E pretreatment group. Therefore, P does not alter the binding properties but rather the intrauterine level of Rc. Treatment with E on day 4, when Rc levels differ between E and E + P groups, stimulated uterine weight and protein content on day 5 in the E pretreatment group. However, minimal stimulation was observed in the E + P pretreatment group. The quantity of RnE and the time of nuclear retention of RnE following E injection on day 4 was greater in the E group than in the E + P group. The effect of progesterone on Rc replenishment was dose-dependent (range, 0.1-2.5 mg; 1/2 maximal, 0.5 mg). Injection of testosterone propionate (1.0 mg), a weak estrogen antagonist, with E on day 3 resulted in slightly reduced levels of Rc on day 4. This reduction also correlated with a reduced sensitivity to treatment with E on day 4. These data, together with previous studies from our laboratory, suggest that progesterone and other estrogen antagonists such as nafoxidine and testosterone propionate inhibit estrogen action by interfering with the replenishment of Rc, thereby reducing the number of receptor estrogen complexes that are translocated and retained by uterine nuclei.


This article has been cited by other articles:


Home page
EndocrinologyHome page
C. Tessier, S. Deb, A. Prigent-Tessier, S. Ferguson-Gottschall, G. B. Gibori, R. P. C. Shiu, and G. Gibori
Estrogen Receptors {alpha} and {beta} in Rat Decidua Cells: Cell-Specific Expression and Differential Regulation by Steroid Hormones and Prolactin
Endocrinology, October 1, 2000; 141(10): 3842 - 3851.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
G. L. Rubin, A. J. Harrold, J. A. Mills, C. N. Falany, and M. W.H. Coughtrie
Regulation of sulphotransferase expression in the endometrium during the menstrual cycle, by oral contraceptives and during early pregnancy
Mol. Hum. Reprod., November 1, 1999; 5(11): 995 - 1002.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
A. G. Herzog
Psychoneuroendocrine Aspects of Temporolimbic Epilepsy: Part I. Brain, Reproductive Steroids, and Emotions
Psychosomatics, April 1, 1999; 40(2): 95 - 101.
[Abstract] [Full Text]


Home page
PsychosomaticsHome page
A. G. Herzog
Psychoneuroendocrine Aspects of Temporolimbic Epilepsy: Part II: Epilepsy and Reproductive Steroids
Psychosomatics, April 1, 1999; 40(2): 102 - 108.
[Abstract] [Full Text]


Home page
PsychosomaticsHome page
A. G. Herzog
Psychoneuroendocrine Aspects of Temporolimbic Epilepsy: Part III: Case Reports
Psychosomatics, April 1, 1999; 40(2): 109 - 116.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
J. D. Graham and C. L. Clarke
Physiological Action of Progesterone in Target Tissues
Endocr. Rev., August 1, 1997; 18(4): 502 - 519.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Fang, S. Wong, and B. F. Mitchell
Effects of RU486 on Estrogen, Progesterone, Oxytocin, and Their Receptors in the Rat Uterus during Late Gestation
Endocrinology, July 1, 1997; 138(7): 2763 - 2768.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
S. Zamudio, K. K. Leslie, M. White, D. D. Hagerman, and L. G. Moore
Low Serum Estradiol and High Serum Progesterone Concentrations Characterize Hypertensive Pregnancies at High Altitude
Reproductive Sciences, July 1, 1994; 1(3): 197 - 205.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1976 by The Endocrine Society